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The number of patients with chronic kidney disease (CKD) is increasing worldwide, with CKD 
now seen as a global epidemic enhanced by increasing rates of diabetes and hypertension. The World 
Health Organization (WHO) estimated that there were 230 million people globally with CKD in 2015. 
This is a concern as it is believed currently only a few countries are able to fully meet the medical 
needs of these patients. This situation will get worse unless this is addressed as a result of increasing 
rates of hypertension and diabetes mellitus, especially in lower and middle-income countries 
(LMICs), which includes Ukraine. It is estimated that by 2030 > 70% of patients worldwide with  
end-stage renal disease (ESRD) will be in developing countries unless key issues and concerns are 
addressed. 
ESRD contributes significantly to morbidity and mortality, decreasing life expectancy, whilst its 
management consumes an appreciable proportion of healthcare resources across countries including 
developing countries. It is estimated that up to 6% of the annual healthcare budget is spent on 
patients with ESRD in developed countries. The optimal management of ESRD requires renal 
replacement therapy in the form of either dialysis or renal transplantation. In the context of 
constrained budgets and rising patient demand for renal transplantation, many countries resort to 
dialysis as the initial preferred option for the management of ESRD. As a result, dialysis programs 
have shown an annual growth approximately 10% over the past 20 years in developing countries. 
Due to an increase in the prevalence and financial burden of ESRD, a number of countries have 
undertaken studies to determine the cost of renal transplantation as well as haemodialysis (HD) and 
peritoneal dialysis (PD). However, these studies have drawn different conclusions, primarily due to 
the economic differences between high-, middle- and low-income countries. The disparities in the 
cost of HD and PD between high-income countries and LMICs might be attributed to a number of 
factors including lower wage rates among healthcare workers in low-income countries, which may 
result in lower costs of HD when compared with PD. PD will generally also cost less in countries that 
have capacity for local manufacture of materials used in PD as well as in countries with a higher 
prevalence of patients undergoing PD owing to economies of scale. This mix of factors will have an 
impact on overall dialysis costs in each country. Although PD is typically less expensive compared 
with HD in many parts of the world, the choice of dialysis modality may be influenced by other 
factors such as patient-population considerations, financial reimbursement, and incentives. 
In Ukraine, in 2018, according to the «National Register of CKD Patients», there were  
8810 patients with ESRD. Among them, 6765 patients were treated by the hemodialysis (for the first 
time this year, 1414 patients), 786 patients were treated by the peritoneal dialysis (137 of them for the 
first time). Kidney transplantation was performed for 1259 patients, of which 112 for the first time. 
The accessibility index for treating patients with hemodialysis and peritoneal dialysis in Ukraine 
is 39% (in the European Union - 92-100%). The prevalence of treatment with these methods in 
Ukraine is 210 per 1 million of the population, and in the European Union - 823 per 1 million. The 
rate of ESRD treatment with kidney transplantation in Ukraine is 3 per 1 million people, which is the 
lowest in Europe (average 32 per 1 million). 
Therefore, it is necessary to conduct a comparative analysis of the cost of treating patients with 
ESRD by kidney transplantation and hemodialysis or peritoneal dialysis to inform future policies in 
Ukraine. 
